“Some days I get up and can’t imagine how considerably we’ve come,” explained Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Scientific tests, a multimillion greenback study and advocacy empire that employs one hundred thirty neuroscien